Efficacy of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients With High Viral Load But Slight Aminotransferase Elevation
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 24 Oct 2017 Preliminary results (n=105) assessing efficacy of tenofovir to prevent liver fibrosis progression, presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases.
- 20 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 29 Jan 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2018 as reported by ClinicalTrials.gov record.